4.6 Article

CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma

Wanjun Chen et al.

Summary: This study analyzed the immune microenvironment of DLBCL patients using the CIBERSORT algorithm and identified the association between activated memory CD4+ T cells and gamma delta T cells with immunochemotherapy response. By constructing gene co-expression networks and protein-protein interaction networks, prognosis-related genes were discovered and their predictive value for immunochemotherapy response was validated. These findings provide new biomarkers and potential therapeutic targets for the treatment and prediction of DLBCL.

MEDICAL ONCOLOGY (2022)

Article Cell Biology

Elucidating minimal residual disease of paediatric B-cell acute lymphoblastic leukaemia by single-cell analysis

Yingchi Zhang et al.

Summary: In this study, Zhang et al. used single-cell transcriptomics and B-cell receptor sequencing to analyze the transcriptomic profiles of B-cell acute lymphoblastic leukaemia cells at diagnosis, residual, and relapse stages. They found that the hypoxia pathway could be a potential target for residual leukaemia cells.

NATURE CELL BIOLOGY (2022)

Article Genetics & Heredity

A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape

Junyu Long et al.

Summary: The mutation-based gene set developed in this study can be used to reliably predict survival benefit across cancers in patients receiving ICI therapy. The gene set is closely associated with immune landscapes and can guide the selection of immunotherapy for cancer patients.

GENOME MEDICINE (2022)

Review Oncology

Tumor-Infiltrating Lymphocytes as Biomarkers of Treatment Response and Long-Term Survival in Patients with Rectal Cancer: A Systematic Review and Meta-Analysis

Adile Orhan et al.

Summary: This study examined tumor-infiltrating lymphocytes (TILs) in pretherapeutic biopsies as biomarkers for treatment response and long-term prognosis in locally advanced rectal cancer patients undergoing neoadjuvant chemoradiotherapy (NCRT). The findings suggest that assessing the density of CD8(+) TILs before treatment can identify a subset of patients with improved treatment response and long-term prognosis. CD8(+) TILs density was also found to be a favorable prognostic factor for disease-free survival and overall survival. Other types of TILs were not identified as predictive or prognostic biomarkers.

CANCERS (2022)

Article Oncology

Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial

Aglaia Schiza et al.

Summary: This study analyzed the clinical impact of tumor-infiltrating lymphocytes (TILs) in patients with ductal carcinoma in situ (DCIS). The results showed that high TILs were associated with an increased risk of ipsilateral breast events (IBEs) over five years post-surgery, particularly for HER2-negative DCIS patients. This indicates that TILs can serve as an important marker to determine the need for adjuvant therapy or potential benefits from immunotherapy in low-risk DCIS patients.

EUROPEAN JOURNAL OF CANCER (2022)

Article Computer Science, Artificial Intelligence

DDTNet: A dense dual-task network for tumor-infiltrating lymphocyte detection and segmentation in histopathological images of breast cancer

Xiaoxuan Zhang et al.

Summary: In this paper, a novel dense dual-task network (DDTNet) is proposed to achieve automatic detection and segmentation of tumor-infiltrating lymphocytes (TILs) in histopathological images. DDTNet utilizes a feature pyramid network for extracting multi-scale morphological characteristics of TILs, a detection module for locating TIL centers, and a segmentation module for delineating TIL boundaries. Experimental results show that DDTNet outperforms other methods in detection and segmentation metrics.

MEDICAL IMAGE ANALYSIS (2022)

Article Oncology

Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer

Alexandra Leary et al.

Summary: This study demonstrates that neoadjuvant chemotherapy significantly impacts the balance of immune subpopulations, with high CD8+/FOXP3+, CD3+/FOXP3+, and CD68+/CD163+ ratios post-chemotherapy associated with improved outcomes. A greater shift towards effector TILs versus regulatory TILs correlates with better survival rates for patients.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Review Oncology

The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition

S. Loi et al.

Summary: The method described in 2014 allows quantification of tumor-infiltrating lymphocytes in breast cancer samples, showing strong prognostic value and potential for use in chemotherapy de-escalation studies. The inclusion of TIL biomarker in international guidelines and its association with better prognoses in TNBC and HER2+ BC have been confirmed. The recent focus has shifted to investigating the clinical utility of TIL in the setting of immune checkpoint-targeted agents, with TIL quantity potentially helping to identify patients who benefit most from PD-1/PD-L1 inhibition.

ANNALS OF ONCOLOGY (2021)

Article Immunology

Tumor-infiltrating B cell is associated with the control of progression of gastric cancer

Zhonglin Ni et al.

Summary: The study found that B cell infiltration, especially class-switched memory B cells and plasma cells, in gastric cancer has a significant impact on tumor progression and prognosis. High levels of CD20+ B cell infiltration were significantly associated with improvements in overall survival and disease-free survival.

IMMUNOLOGIC RESEARCH (2021)

Article Pharmacology & Pharmacy

p-MEK expression predicts prognosis of patients with adenocarcinoma of esophagogastric junction (AEG) and plays a role in anti-AEG efficacy of Huaier

Li Yuan et al.

Summary: This study demonstrated that high expression of p-MEK may be an independent factor of poor prognosis in patients with AEG, and the traditional Chinese medicine Huaier exerts its anti-AEG efficacy by inhibiting the MEK/ERK signaling pathway both in vitro and in vivo.

PHARMACOLOGICAL RESEARCH (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer-T cell coculture models

Kosaku Mimura et al.

Summary: This study found that the co-expression of inhibitory ligands for PD-1, Tim-3, and Lag-3 was highest in GC patients. CEACAM-1, LSECtin, and MHC-II expression correlated significantly with PD-L1 expression and overall survival. Combined immunotherapy targeting PD-1, Tim-3, and Lag-3 showed therapeutic potential in GC patients.

GASTRIC CANCER (2021)

Article Biotechnology & Applied Microbiology

CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma

Zhihuai Wang et al.

Summary: CDCA3 is highly expressed in various cancers, related to patient prognosis, and influences immune cell infiltration. This suggests that CDCA3 may be a potential target and biomarker for the management and diagnosis of HCC.

BIOMED RESEARCH INTERNATIONAL (2021)

Article Biochemistry & Molecular Biology

Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma

Zhihua Zuo et al.

Summary: This study identified an immune-related prognostic signature for CESC patients based on analysis of TCGA and GEO databases. The three-IRGs signature was not only reliable for survival prediction but also efficient in predicting the clinical response to immunotherapy, with low-risk patients showing better responses and prognoses.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Oncology

Clinicopathological and prognostic significance of programmed death ligant-1 expression in gastric cancer: a meta-analysis

Zhebing Qiu et al.

Summary: The high expression of PD-L1 in gastric cancer is associated with lower survival rates and lymph node metastasis, but not with tumor stage. This suggests that PD-L1 may be a potential prognostic factor in gastric cancer.

JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)

Article Genetics & Heredity

Identification of Immune-Related Genes Associated With Bladder Cancer Based on Immunological Characteristics and Their Correlation With the Prognosis

Zhen Kang et al.

Summary: This study identified immune-related prognostic genes in bladder cancer and established a prognostic model and diagnostic nomogram with good predictive ability and accuracy. These genes may serve as promising candidates for therapeutic targets, although further experimental studies are needed to reveal their mechanisms in mediating the progression of bladder cancer.

FRONTIERS IN GENETICS (2021)

Review Oncology

Immunomodulating Therapies in Breast Cancer-From Prognosis to Clinical Practice

Marcus Schmidt et al.

Summary: The immune system plays a crucial role in breast cancer, particularly in triple negative breast cancer. Personalized mRNA vaccines targeting tumor-specific neoantigens and immune checkpoint inhibitors are emerging as promising treatment strategies.

CANCERS (2021)

Article Oncology

Transcriptomic Correlates of Immunologic Activation in Head and Neck and Cervical Cancer

Cristina Saiz-Ladera et al.

Summary: A group of gene combination associated with favorable outcome in HNSCC and CSCC has been identified, linked to an increase of immune effector cells in the tumor. However, these findings were not reproduced in other squamous cell carcinoma types. Prospective confirmatory studies are needed for validation.

FRONTIERS IN ONCOLOGY (2021)

Article Multidisciplinary Sciences

Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures

Linyu Peng et al.

Summary: The study aims to find a Tumor microenvironment prognostic marker for predicting the survival of cervical cancer patients by analyzing transcriptional sequencing data. The TMEscore model showed good results in survival prediction, with significant differences in prognosis between high/low TMEscore groups mainly in immune function-related pathways. Identified prognosis genes may provide new strategies for tumor immunotherapy, with potential new targets such as CD3D, CD3E, CD8A, CD27 identified through PPI network analysis.

PLOS ONE (2021)

Article Oncology

Cytotoxic T-lymphocyte-associated protein 4 in gastric cancer: Prognosis and association with PD-L1 expression

Marina Alessandra Pereira et al.

Summary: CTLA-4 positivity in gastric cancer is associated with PD-L1 expression and high tumor-infiltrating CD8+ T cells. In addition, positivity for both CTLA-4 and PD-L1 is an independent factor associated with better survival in gastric cancer patients.

JOURNAL OF SURGICAL ONCOLOGY (2021)

Article Genetics & Heredity

Multi-Omics Data Analyses Construct a Six Immune-Related Genes Prognostic Model for Cervical Cancer in Tumor Microenvironment

Fangfang Xu et al.

Summary: The study identified eight hub immune-related prognostic genes and constructed an immune gene-related prognostic model (IGRPM) with six factors to predict clinical outcomes of CC patients. The predictive capability of the model was further assessed and validated using the Gene Expression Omnibus validation set, showing promising results for predicting prognoses and responses to immunotherapy for CC patients.

FRONTIERS IN GENETICS (2021)

Article Gastroenterology & Hepatology

The Immune Microenvironment Impacts Survival in Western Patients with Gastric Adenocarcinoma

Abhineet Uppal et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2020)

Article Medicine, General & Internal

Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis and experimental validation

Nana Zhang et al.

ARCHIVES OF MEDICAL SCIENCE (2020)

Article Biochemistry & Molecular Biology

Recovery and analysis of transcriptome subsets from pooled single-cell RNA-seq libraries

Kent A. Riemondy et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Oncology

Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes

Balazs Gyorffy et al.

INTERNATIONAL JOURNAL OF CANCER (2016)